Lidds AB logo

LIDDS - Lidds AB Share Price

SEK15.7 0.2  1.3%

Last Trade - 06/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £29.8m
Enterprise Value £29.1m
Revenue £622k
Position in Universe 1055th / 1558
Bullish
Bearish
Unlock LIDDS Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LIDDS Revenue Unlock LIDDS Revenue

Net Income

LIDDS Net Income Unlock LIDDS Revenue

Normalised EPS

LIDDS Normalised EPS Unlock LIDDS Revenue

PE Ratio Range

LIDDS PE Ratio Range Unlock LIDDS Revenue

Dividend Yield Range

LIDDS Dividend Yield Range Unlock LIDDS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LIDDS EPS Forecasts Unlock LIDDS Revenue
Profile Summary

Lidds AB (LIDDS) is a Sweden-based company engaged in the development of pharmaceutical products. LIDDS (Local Intelligent Drug Delivery System) uses its drug delivery technology, a parenteral, microparticulate drug carrier matrix, which is administered as a paste that spreads in the tissue and ultimately cures shortly after injection, allowing local treatment at site of disease. It targets primarily solid tumors. The Company’s portfolio includes Liproca Depot, aimed at prostate cancer with possible applications in benign prostate hypertrophy (BPH). The Liproca Depot is a bioresorbable, biocompatible and locally injectable modified release formulation of 2-hydroxyflutamid, prepared as a paste prior to injection.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Public Since July 31, 2014
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 23,692,388
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address Virdings Alle 32 B, UPPSALA, 754 50, Sweden
Web http://www.lidds.se/
Phone +46 42 387427
Contact ()
Auditors Mazars SET Revisionsbyra AB
LIDDS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to LIDDS
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.